A Honor Society of Nursing (STTI) answered. The rate of incidence for pancreatitis each year in the United States is over 300,000 people. Roughly 200,000 people are hospitalized each year for treatment of acute pancreatitis.
As reported in Diabetes Technology & Management, recent research shows that smaller 8 millimeter (mm), 6 mm, and 4 mm needles are as effective, regardless of body mass. This makes insulin injections more acceptable and less painful than it was in the past.
Insulin is available in rapid-, short-, intermediate-, and long-acting types that may be injected separately or mixed in the same syringe. Rapid-acting insulin analogs (insulin lispro and insulin aspart) are available, and other analogs are in development. Regular is a short-acting insulin.